Deazapurines useful as inhibitors of Janus kinases
US8741912B2 · kind B2 · utility
2Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2007 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Mar 29, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds useful as inhibitors of protein kinases, particularly of JAK family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The compounds are generally represented by structural formula I or pharmaceutically acceptable salts thereof:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.